Literature DB >> 35638925

Traction Bronchiectasis/Bronchiolectasis on CT Scans in Relationship to Clinical Outcomes and Mortality: The COPDGene Study.

Akinori Hata1, Takuya Hino1, Rachel K Putman1, Masahiro Yanagawa1, Tomoyuki Hida1, Aravind A Menon1, Osamu Honda1, Yoshitake Yamada1, Mizuki Nishino1, Tetsuro Araki1, Vladimir I Valtchinov1, Masahiro Jinzaki1, Hiroshi Honda1, Kousei Ishigami1, Takeshi Johkoh1, Noriyuki Tomiyama1, David C Christiani1, David A Lynch1, Raúl San José Estépar1, George R Washko1, Michael H Cho1, Edwin K Silverman1, Gary M Hunninghake1, Hiroto Hatabu1.   

Abstract

Background The clinical impact of interstitial lung abnormalities (ILAs) on poor prognosis has been reported in many studies, but risk stratification in ILA will contribute to clinical practice. Purpose To investigate the association of traction bronchiectasis/bronchiolectasis index (TBI) with mortality and clinical outcomes in individuals with ILA by using the COPDGene cohort. Materials and Methods This study was a secondary analysis of prospectively collected data. Chest CT scans of participants with ILA for traction bronchiectasis/bronchiolectasis were evaluated and outcomes were compared with participants without ILA from the COPDGene study (January 2008 to June 2011). TBI was classified as follows: TBI-0, ILA without traction bronchiectasis/bronchiolectasis; TBI-1, ILA with bronchiolectasis but without bronchiectasis or architectural distortion; TBI-2, ILA with mild to moderate traction bronchiectasis; and TBI-3, ILA with severe traction bronchiectasis and/or honeycombing. Clinical outcomes and overall survival were compared among the TBI groups and the non-ILA group by using multivariable linear regression model and Cox proportional hazards model, respectively. Results Overall, 5295 participants (median age, 59 years; IQR, 52-66 years; 2779 men) were included, and 582 participants with ILA and 4713 participants without ILA were identified. TBI groups were associated with poorer clinical outcomes such as quality of life scores in the multivariable linear regression model (TBI-0: coefficient, 3.2 [95% CI: 0.6, 5.7; P = .01]; TBI-1: coefficient, 3.3 [95% CI: 1.1, 5.6; P = .003]; TBI-2: coefficient, 7.6 [95% CI: 4.0, 11; P < .001]; TBI-3: coefficient, 32 [95% CI: 17, 48; P < .001]). The multivariable Cox model demonstrated that ILA without traction bronchiectasis (TBI-0-1) and with traction bronchiectasis (TBI-2-3) were associated with shorter overall survival (TBI-0-1: hazard ratio [HR], 1.4 [95% CI: 1.0, 1.9; P = .049]; TBI-2-3: HR, 3.8 [95% CI: 2.6, 5.6; P < .001]). Conclusion Traction bronchiectasis/bronchiolectasis was associated with poorer clinical outcomes compared with the group without interstitial lung abnormalities; TBI-2 and 3 were associated with shorter survival. © RSNA, 2022 Online supplemental material is available for this article. See also the editorial by Lee and Im in this issue.

Entities:  

Mesh:

Year:  2022        PMID: 35638925      PMCID: PMC9434811          DOI: 10.1148/radiol.212584

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   29.146


  36 in total

1.  Connective tissue disease related fibrotic lung disease: high resolution computed tomographic and pulmonary function indices as prognostic determinants.

Authors:  Simon L F Walsh; Nicola Sverzellati; Anand Devaraj; Gregory J Keir; Athol U Wells; David M Hansell
Journal:  Thorax       Date:  2013-10-14       Impact factor: 9.139

2.  Imaging Patterns Are Associated with Interstitial Lung Abnormality Progression and Mortality.

Authors:  Rachel K Putman; Gunnar Gudmundsson; Gisli Thor Axelsson; Tomoyuki Hida; Osamu Honda; Tetsuro Araki; Masahiro Yanagawa; Mizuki Nishino; Ezra R Miller; Gudny Eiriksdottir; Elías F Gudmundsson; Noriyuki Tomiyama; Hiroshi Honda; Ivan O Rosas; George R Washko; Michael H Cho; David A Schwartz; Vilmundur Gudnason; Hiroto Hatabu; Gary M Hunninghake
Journal:  Am J Respir Crit Care Med       Date:  2019-07-15       Impact factor: 21.405

3.  Histopathology of Interstitial Lung Abnormalities in the Context of Lung Nodule Resections.

Authors:  Ezra R Miller; Rachel K Putman; Marina Vivero; Yin Hung; Tetsuro Araki; Mizuki Nishino; George R Washko; Ivan O Rosas; Hiroto Hatabu; Lynette M Sholl; Gary M Hunninghake
Journal:  Am J Respir Crit Care Med       Date:  2018-04-01       Impact factor: 21.405

4.  Predicting Outcome in Idiopathic Pulmonary Fibrosis: Addition of Fibrotic Score at Thin-Section CT of the Chest to Gender, Age, and Physiology Score Improves the Prediction Model.

Authors:  Anurag Chahal; Roozbeh Sharif; Jubal Watts; Joao de Andrade; Tracy Luckhardt; Young-Il Kim; Rekha Ramchandran; Sushilkumar Sonavane
Journal:  Radiol Cardiothorac Imaging       Date:  2019-06-27

5.  Clinical characteristics of combined pulmonary fibrosis and emphysema.

Authors:  Yoshiaki Kitaguchi; Keisaku Fujimoto; Masayuki Hanaoka; Satoshi Kawakami; Takayuki Honda; Keishi Kubo
Journal:  Respirology       Date:  2009-12-27       Impact factor: 6.424

6.  MUC5B promoter polymorphism and interstitial lung abnormalities.

Authors:  Gary M Hunninghake; Hiroto Hatabu; Yuka Okajima; Wei Gao; Josée Dupuis; Jeanne C Latourelle; Mizuki Nishino; Tetsuro Araki; Oscar E Zazueta; Sila Kurugol; James C Ross; Raúl San José Estépar; Elissa Murphy; Mark P Steele; James E Loyd; Marvin I Schwarz; Tasha E Fingerlin; Ivan O Rosas; George R Washko; George T O'Connor; David A Schwartz
Journal:  N Engl J Med       Date:  2013-05-21       Impact factor: 91.245

7.  Association Between Interstitial Lung Abnormalities and All-Cause Mortality.

Authors:  Rachel K Putman; Hiroto Hatabu; Tetsuro Araki; Gunnar Gudmundsson; Wei Gao; Mizuki Nishino; Yuka Okajima; Josée Dupuis; Jeanne C Latourelle; Michael H Cho; Souheil El-Chemaly; Harvey O Coxson; Bartolome R Celli; Isis E Fernandez; Oscar E Zazueta; James C Ross; Rola Harmouche; Raúl San José Estépar; Alejandro A Diaz; Sigurdur Sigurdsson; Elías F Gudmundsson; Gudny Eiríksdottír; Thor Aspelund; Matthew J Budoff; Gregory L Kinney; John E Hokanson; Michelle C Williams; John T Murchison; William MacNee; Udo Hoffmann; Christopher J O'Donnell; Lenore J Launer; Tamara B Harrris; Vilmundur Gudnason; Edwin K Silverman; George T O'Connor; George R Washko; Ivan O Rosas; Gary M Hunninghake
Journal:  JAMA       Date:  2016-02-16       Impact factor: 56.272

8.  Clinical Features and Outcomes of Combined Pulmonary Fibrosis and Emphysema After Lung Transplantation.

Authors:  Tsuyoshi Takahashi; Yuriko Terada; Michael K Pasque; Jingxia Liu; Derek E Byers; Chad A Witt; Ruben G Nava; Varun Puri; Benjamin D Kozower; Bryan F Meyers; Daniel Kreisel; G Alexander Patterson; Ramsey R Hachem
Journal:  Chest       Date:  2021-06-26       Impact factor: 9.410

9.  An increased risk of lung cancer in combined pulmonary fibrosis and emphysema patients with usual interstitial pneumonia compared with patients with idiopathic pulmonary fibrosis alone: a systematic review and meta-analysis.

Authors:  Qianqian Chen; Ping Liu; Hong Zhou; Hui Kong; Weiping Xie
Journal:  Ther Adv Respir Dis       Date:  2021 Jan-Dec       Impact factor: 4.031

10.  Progression of traction bronchiectasis/bronchiolectasis in interstitial lung abnormalities is associated with increased all-cause mortality: Age Gene/Environment Susceptibility-Reykjavik Study.

Authors:  Takuya Hino; Tomoyuki Hida; Mizuki Nishino; Junwei Lu; Rachel K Putman; Elias F Gudmundsson; Akinori Hata; Tetsuro Araki; Vladimir I Valtchinov; Osamu Honda; Masahiro Yanagawa; Yoshitake Yamada; Takeshi Kamitani; Masahiro Jinzaki; Noriyuki Tomiyama; Kousei Ishigami; Hiroshi Honda; Raul San Jose Estepar; George R Washko; Takeshi Johkoh; David C Christiani; David A Lynch; Vilmundur Gudnason; Gunnar Gudmundsson; Gary M Hunninghake; Hiroto Hatabu
Journal:  Eur J Radiol Open       Date:  2021-03-10
View more
  1 in total

1.  Traction bronchiectasis: is it as benign as we think?

Authors:  Amina Bekki; Thais Beauperthuy; Miguel Ángel Martínez-García
Journal:  J Bras Pneumol       Date:  2022-07-25       Impact factor: 2.800

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.